Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Chengdu Scimount Pharmatech Co., Ltd.

Clinical trials sponsored by Chengdu Scimount Pharmatech Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

Can a new drug outsmart resistant breast cancer? Results expected Jul 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet recruiting 1

Can a new drug outsmart resistant breast cancer?

Disease control Not yet recruiting

This phase II trial is testing an experimental drug called SMP-656 in people with HER2-positive breast cancer that has spread or cannot be removed and has worsened after prior treatment with a specific type of antibody-drug conjugate. The study aims to see if SMP-656 can shrink t…

Phase 2 • Sponsor: Chengdu SciMount Pharmatech Co., Ltd. • Aim: Disease control

Last updated Jul 26, 2026 00:00 UTC